Yanli Xing

539 total citations
22 papers, 431 citations indexed

About

Yanli Xing is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Yanli Xing has authored 22 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Yanli Xing's work include Traditional Chinese Medicine Analysis (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Tryptophan and brain disorders (3 papers). Yanli Xing is often cited by papers focused on Traditional Chinese Medicine Analysis (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Tryptophan and brain disorders (3 papers). Yanli Xing collaborates with scholars based in China. Yanli Xing's co-authors include Jingwei Tian, Yonglin Gao, Jian Hou, Jingyu Shen, Haibo Zhu, Jingwei Tian, Chunmei Li, Chunmei Li, Haibo Zhu and Hiroshi Kurihara and has published in prestigious journals such as Neuroscience, Journal of Medicinal Chemistry and Frontiers in Immunology.

In The Last Decade

Yanli Xing

22 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanli Xing China 11 131 63 61 53 51 22 431
Ziwei Chen China 11 113 0.9× 65 1.0× 15 0.2× 84 1.6× 26 0.5× 28 394
Rosaria Salvatore Italy 8 139 1.1× 28 0.4× 12 0.2× 78 1.5× 21 0.4× 9 516
Ming Bai China 15 275 2.1× 62 1.0× 7 0.1× 70 1.3× 77 1.5× 62 615
Jia Zhao Hong Kong 12 188 1.4× 53 0.8× 6 0.1× 80 1.5× 37 0.7× 22 475
Shu‐Hua Ouyang China 12 228 1.7× 39 0.6× 6 0.1× 51 1.0× 48 0.9× 24 625
Yanqiu Cui China 9 133 1.0× 9 0.1× 163 2.7× 105 2.0× 67 1.3× 14 470
lew jaehwan South Korea 8 97 0.7× 12 0.2× 11 0.2× 35 0.7× 80 1.6× 21 339
Jian Bao China 13 178 1.4× 37 0.6× 9 0.1× 234 4.4× 76 1.5× 26 688
Federica Varsaldi Italy 10 130 1.0× 11 0.2× 9 0.1× 69 1.3× 18 0.4× 10 494
Changjiang Ying China 14 132 1.0× 16 0.3× 6 0.1× 76 1.4× 16 0.3× 36 522

Countries citing papers authored by Yanli Xing

Since Specialization
Citations

This map shows the geographic impact of Yanli Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanli Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanli Xing more than expected).

Fields of papers citing papers by Yanli Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanli Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanli Xing. The network helps show where Yanli Xing may publish in the future.

Co-authorship network of co-authors of Yanli Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Yanli Xing. A scholar is included among the top collaborators of Yanli Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanli Xing. Yanli Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xing, Yanli, et al.. (2023). The Relationship Between Prognostic Nutritional Indexes and the Clinical Outcomes of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of COPD. Volume 18. 1155–1167. 4 indexed citations
2.
Xing, Yanli, Hongmei Li, Ting Yuan, et al.. (2023). Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer. Frontiers in Immunology. 14. 1193040–1193040. 8 indexed citations
3.
Xing, Yanli, Hongmei Li, Bing Liang, et al.. (2022). Simultaneous Gemcitabine and Percutaneous CT-Guided Irreversible Electroporation for Locally Advanced Pancreatic Cancer. Journal of Oncology. 2022. 1–12. 3 indexed citations
6.
Xing, Yanli, et al.. (2021). Effect of Community-Acquired Pneumonia on Acute Exacerbation of Chronic Obstructive Pulmonary Disease. COPD Journal of Chronic Obstructive Pulmonary Disease. 18(4). 417–424. 7 indexed citations
7.
Li, Jianfeng, et al.. (2021). Development of a Predictive Model for Mortality in Hospitalized Patients With COVID-19. Disaster Medicine and Public Health Preparedness. 16(4). 1398–1406. 5 indexed citations
8.
Chen, Li-Mei, He Chen, Yanli Xing, & Juan Li. (2021). ABCC1 regulates cocaine-associated memory, spine plasticity and GluA1 and GluA2 surface expression. Neuroreport. 32(10). 833–839. 3 indexed citations
9.
Shen, Hui, Yan Zhang, Chao Wang, et al.. (2021). Discovery and Characterization of Benzimidazole Derivative XY123 as a Potent, Selective, and Orally Available RORγ Inverse Agonist. Journal of Medicinal Chemistry. 64(12). 8775–8797. 12 indexed citations
11.
Xing, Yanli, et al.. (2014). Evaluation of Galactomannan Enzyme Immunoassay and Quantitative Real-Time PCR for the Diagnosis of Invasive Pulmonary Aspergillosis in a Rat Model. Journal of Microbiology and Biotechnology. 24(8). 1044–1050. 6 indexed citations
12.
Hou, Jian, Yanli Xing, Daiying Zuo, et al.. (2014). In vitro and in vivo characterization of PA01, a novel promising triple reuptake inhibitor. Physiology & Behavior. 138. 141–149. 4 indexed citations
13.
Li, Chunmei, Jie He, Yonglin Gao, et al.. (2013). Preventive Effect of Total Flavones of Choerospondias axillaries on Ischemia/Reperfusion-Induced Myocardial Infarction-Related MAPK Signaling Pathway. Cardiovascular Toxicology. 14(2). 145–152. 45 indexed citations
14.
Xing, Yanli, et al.. (2013). Gender differences in CMS and the effects of antidepressant venlafaxine in rats. Neurochemistry International. 63(6). 570–575. 59 indexed citations
15.
Li, Chunmei, Yonglin Gao, Jingwei Tian, et al.. (2012). Long-term oral Asperosaponin VI attenuates cardiac dysfunction, myocardial fibrosis in a rat model of chronic myocardial infarction. Food and Chemical Toxicology. 50(5). 1432–1438. 31 indexed citations
16.
Li, Chunmei, Yonglin Gao, Yanli Xing, et al.. (2011). Fucoidan, a sulfated polysaccharide from brown algae, against myocardial ischemia–reperfusion injury in rats via regulating the inflammation response. Food and Chemical Toxicology. 49(9). 2090–2095. 97 indexed citations
17.
Tian, Jingwei, Wanglin Jiang, Qingguo Meng, et al.. (2011). Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties. Neuroscience. 196. 124–130. 15 indexed citations
18.
Li, Chunmei, Jingwei Tian, Wanglin Jiang, et al.. (2010). Asperosaponin VI protects cardiac myocytes from hypoxia-induced apoptosis via activation of the PI3K/Akt and CREB pathways. European Journal of Pharmacology. 649(1-3). 100–107. 45 indexed citations
19.
Jian-xiong, Yang, Jingwei Tian, Chunmei Li, et al.. (2009). Cardioprotective Effect of SMND‐309, A Novel Derivate of Salvianolic Acid B on Acute Myocardial Infarction in Rats. Basic & Clinical Pharmacology & Toxicology. 106(4). 317–323. 14 indexed citations
20.
Li, Shuqin, et al.. (2009). Activation of NMDA Receptor is Associated with Up-regulation of COX-2 Expression in the Spinal Dorsal Horn during Nociceptive Inputs in Rats. Neurochemical Research. 34(8). 1451–1463. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026